Education
About Us
Working with TipRanks
Follow Us
OpGen Inc (OPGN)
OTHER OTC:OPGN
OPGN Stock Chart & Stats
$13.18
-$0.03(-3.00%)
At close: 4:00 PM EST
$13.18
-$0.03(-3.00%)
Day’s Range― - ―
52-Week Range$0.04 - $10.90
Previous CloseN/A
Volume983.00
Average Volume (3M)1.29K
Market Cap
$125.64M
Enterprise Value$13.75M
Total Cash (Recent Filing)$414.21K
Total Debt (Recent Filing)$1.89M
Price to Earnings (P/E)33.0
Beta-10753.73
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.96
Shares Outstanding10,071,286
10 Day Avg. Volume0
30 Day Avg. Volume1,287
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.38
Price to Sales (P/S)0.53
P/FCF Ratio-0.57
Enterprise Value/Market Cap0.11
Enterprise Value/Revenue1.53
Enterprise Value/Gross Profit1.54
Enterprise Value/Ebitda1.90
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
OpGen News
OPGN FAQ
What was OpGen Inc’s price range in the past 12 months?
OpGen Inc lowest stock price was $0.04 and its highest was $10.90 in the past 12 months.
What is OpGen Inc’s market cap?
OpGen Inc’s market cap is $125.64M.
When is OpGen Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were OpGen Inc’s earnings last quarter?
OpGen Inc released its earnings results on Aug 08, 2024. The company reported -$1.176 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.176.
Is OpGen Inc overvalued?
According to Wall Street analysts OpGen Inc’s price is currently Overvalued.
Does OpGen Inc pay dividends?
OpGen Inc does not currently pay dividends.
What is OpGen Inc’s EPS estimate?
OpGen Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OpGen Inc have?
OpGen Inc has 10,071,286 shares outstanding.
What happened to OpGen Inc’s price movement after its last earnings report?
OpGen Inc reported an EPS of -$1.176 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -12.5%.
Which hedge fund is a major shareholder of OpGen Inc?
Currently, no hedge funds are holding shares in OPGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
OpGen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
-98.30%
12-Months-Change
Fundamentals
Return on Equity
-331.94%
Trailing 12-Months
Asset Growth
-69.84%
Trailing 12-Months
Company Description
OpGen Inc
OpGen, Inc. is a precision medicine company focused on combating infectious diseases through its innovative molecular diagnostics and informatics technology. The company operates in the biotechnology and healthcare sectors, providing advanced solutions for the detection and treatment of multi-drug resistant pathogens. OpGen's core products include the Acuitas AMR Gene Panel, which identifies bacterial pathogens and resistance genes, and the Unyvero platform, a rapid diagnostic system for severe infections.
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---